Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Haematologica
|
September 1, 1975
Hyperbasophilic cells in malignant lymphomas
V Liso, A Riezzo, G Troccoli
Minerva Ginecologica
|
December 1, 1977
[Vulvar neoplasms (myeloblastoma) as the first manifestation of acute myeloblastic leukemia]
R Laricchia, T Wierdis, L Loiudice, et al.
Haematologica
|
July 1, 1983
Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment
V Liso, G Specchia, V Pavone, et al.
Blut
|
November 1, 1983
Acute lymphoblastic leukemia hand-mirror cells. Study of nine cases
V Liso, G Specchia, V Pavone, et al.
Blut
|
October 1, 1986
Acute lymphoblastic leukemia hand-mirror cells with OKT 8 phenotype
V Liso, G Specchia, V Pavone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2006
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL)
P G Gobbi, C Broglia, F Valentino, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Haematologica
|
September 1, 1975
Hyperbasophilic cells in malignant lymphomas
V Liso, A Riezzo, G Troccoli
Minerva Ginecologica
|
December 1, 1977
[Vulvar neoplasms (myeloblastoma) as the first manifestation of acute myeloblastic leukemia]
R Laricchia, T Wierdis, L Loiudice, et al.
Haematologica
|
July 1, 1983
Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment
V Liso, G Specchia, V Pavone, et al.
Blut
|
November 1, 1983
Acute lymphoblastic leukemia hand-mirror cells. Study of nine cases
V Liso, G Specchia, V Pavone, et al.
Blut
|
October 1, 1986
Acute lymphoblastic leukemia hand-mirror cells with OKT 8 phenotype
V Liso, G Specchia, V Pavone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2006
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL)
P G Gobbi, C Broglia, F Valentino, et al.
Page
of 1